Melanoma Treatment Market: By Treatment, By Class of Drugs, By Distribution Channel and Region Forecast 2019-2030

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Melanoma Treatment Market Size, Share, Growth, Trends, and Global Industry Analysis: By Treatment (Targeted Therapy, Chemotherapy, Radiation Therapy, Biological Therapy), By Class of Drugs ( MEK Inhibitors, Monoclonal Antibodies, BRAF Inhibitors, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region Forecast 2019-2030

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Melanoma Treatment Market size was valued at US$ 3.26 billion in 2023 and is expected to reach US$ 7.19 billion by 2030, with a CAGR of 16% from 2024-2030. Melanoma is the more serious type of cancer that develops in cells of the skin called melanocytes that produce melanin. Melanoma not only affects the skin but also affects the eyes and rarely, affects internal organs such as the intestine. The exact cause of melanoma is not clearly known, but the exposure of skin to UV radiation or tanning lumps and beds increases the risk of developing melanoma. Upsurge in the global melanoma prevalence rates and pipeline drugs for the treatment of melanoma are projected to boost the global market at significant rates over the forecast period.

According to the World Health Organization (WHO), there is a continuous increase in the global prevalence of melanoma, and estimated that 132,000 melanoma skin cancers occur every year. Companies in the marketplace are focused on the development of new drug treatments and the identification of different novel targets for the treatment of melanoma. For instance, binimetinib is being developed by Array BioPharma under phase 3 clinical trials for various types of cancers including melanoma. Furthermore, companies also focus on collaborations and acquisitions to develop new drug treatments and expand their portfolio in the market.

Key Developments

  • In September 2017 Merck Sharp & Dohme launched its blockbuster drug Keytruda in India for the treatment of unresectable or metastatic melanoma.

summary download arrow Download Free Sample

Melanoma Treatment Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

16%

Largest Market

North America

Fastest Growing Market

Asia pacific

Melanoma Treatment Market Dynamics

The market is primarily driven by the increase in number of people suffering from melanoma coupled with the advancements and new drug approvals such as keytruda, vemurafenib, dabrafenib and nivolumab for the treatment of melanoma. In addition, growing number of drug developments, current pipeline drugs and their expected approvals during the forecast period projected to boost the market over the forecast period. Furthermore, increase in government support and R&D activities to fight against cancer coupled with various initiatives by government and non-government organizations expected to bolster the market growth over the forecast period.

Melanoma Treatment Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 3.26 billion

Market Size in 2030

US$ 7.19 billion

Market CAGR

16%

By Based on Treatment

  • Targeted Therapy
  • Chemotherapy
  • Radiation Therapy
  • Biological Therapy

By Class of Drugs

  • MEK Inhibitors
  • Monoclonal Antibodies
  • BRAF Inhibitors
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa) 

Key Features of the Report

  • The melanoma treatment market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies.
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
  • The report provides a plethora of information about Market entry strategies, regulatory framework, and reimbursement scenarios.
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The melanoma treatment market size was valued at US$ 3.26 bn in 2023 and is expected to reach US$ 7.19 bn by 2030, with a CAGR of 16% from 2024-2030

The market key players are: Hoffmann-La Roche Ltd. (Switzerland) Bristol-Myers Squibb (U.S.) Novartis AG (Switzerland) Genetech Inc. (U.S.) AstraZeneca plc (U.K.) Polynoma LLC (CK Life Sciences) (Hong Kong) Sanofi S.A. (France) Amgen Inc. (U.S.) Takeda Pharmaceutical Company (Japan) Merck & Co. Inc. (U.S.)

The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Melanoma Treatment Market Introduction 
2.1.Global Melanoma Treatment Market  - Taxonomy
2.2.Global Melanoma Treatment Market  - Definitions
2.2.1.Based on Treatment
2.2.2.Class of Drugs
2.2.3.Distribution Channel
2.2.4.Geography
2.2.5.Region
3. Global Melanoma Treatment Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Melanoma Treatment Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Melanoma Treatment Market  By Based on Treatment, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Targeted Therapy
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Chemotherapy
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Radiation Therapy
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Biological Therapy
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6. Global Melanoma Treatment Market  By Class of Drugs, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. MEK Inhibitors
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Monoclonal Antibodies
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. BRAF Inhibitors
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Others
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7. Global Melanoma Treatment Market  By Distribution Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Hospital Pharmacies
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Retail Pharmacies
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Online Pharmacies
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8. Global Melanoma Treatment Market  By Geography, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia-Pacific
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Latin America
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Middle East and Africa (MEA)
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9. Global Melanoma Treatment Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10. North America Melanoma Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Based on Treatment Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Targeted Therapy
10.1.2.Chemotherapy
10.1.3.Radiation Therapy
10.1.4.Biological Therapy
10.2.  Class of Drugs Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.MEK Inhibitors
10.2.2.Monoclonal Antibodies
10.2.3.BRAF Inhibitors
10.2.4.Others
10.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospital Pharmacies
10.3.2.Retail Pharmacies
10.3.3.Online Pharmacies
10.4.  Geography Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.North America
10.4.2.Europe
10.4.3.Asia-Pacific
10.4.4.Latin America
10.4.5.Middle East and Africa (MEA)
10.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11. Europe Melanoma Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Based on Treatment Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Targeted Therapy
11.1.2.Chemotherapy
11.1.3.Radiation Therapy
11.1.4.Biological Therapy
11.2.  Class of Drugs Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.MEK Inhibitors
11.2.2.Monoclonal Antibodies
11.2.3.BRAF Inhibitors
11.2.4.Others
11.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospital Pharmacies
11.3.2.Retail Pharmacies
11.3.3.Online Pharmacies
11.4.  Geography Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.North America
11.4.2.Europe
11.4.3.Asia-Pacific
11.4.4.Latin America
11.4.5.Middle East and Africa (MEA)
11.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12. Asia Pacific (APAC) Melanoma Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Based on Treatment Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Targeted Therapy
12.1.2.Chemotherapy
12.1.3.Radiation Therapy
12.1.4.Biological Therapy
12.2.  Class of Drugs Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.MEK Inhibitors
12.2.2.Monoclonal Antibodies
12.2.3.BRAF Inhibitors
12.2.4.Others
12.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospital Pharmacies
12.3.2.Retail Pharmacies
12.3.3.Online Pharmacies
12.4.  Geography Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.North America
12.4.2.Europe
12.4.3.Asia-Pacific
12.4.4.Latin America
12.4.5.Middle East and Africa (MEA)
12.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13. Middle East and Africa (MEA) Melanoma Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Based on Treatment Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Targeted Therapy
13.1.2.Chemotherapy
13.1.3.Radiation Therapy
13.1.4.Biological Therapy
13.2.  Class of Drugs Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.MEK Inhibitors
13.2.2.Monoclonal Antibodies
13.2.3.BRAF Inhibitors
13.2.4.Others
13.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospital Pharmacies
13.3.2.Retail Pharmacies
13.3.3.Online Pharmacies
13.4.  Geography Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.North America
13.4.2.Europe
13.4.3.Asia-Pacific
13.4.4.Latin America
13.4.5.Middle East and Africa (MEA)
13.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14. Latin America Melanoma Treatment Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
14.1. Based on Treatment Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Targeted Therapy
14.1.2.Chemotherapy
14.1.3.Radiation Therapy
14.1.4.Biological Therapy
14.2.  Class of Drugs Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.MEK Inhibitors
14.2.2.Monoclonal Antibodies
14.2.3.BRAF Inhibitors
14.2.4.Others
14.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Hospital Pharmacies
14.3.2.Retail Pharmacies
14.3.3.Online Pharmacies
14.4.  Geography Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.North America
14.4.2.Europe
14.4.3.Asia-Pacific
14.4.4.Latin America
14.4.5.Middle East and Africa (MEA)
14.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Hoffmann-La Roche Ltd. (Switzerland)
15.2.2.Bristol-Myers Squibb (U.S.)
15.2.3.Novartis AG (Switzerland)
15.2.4.Genetech Inc. (U.S.)
15.2.5.AstraZeneca plc (U.K.)
15.2.6.Polynoma LLC (CK Life Sciences) (Hong Kong)
15.2.7.Sanofi S.A. (France)
15.2.8.Amgen Inc. (U.S.)
15.2.9.Takeda Pharmaceutical Company (Japan)
15.2.10.Merck & Co. Inc. (U.S.)
16. Research Methodology 
17. Appendix and Abbreviations 

Key Market Players

  • Hoffmann-La Roche Ltd. (Switzerland)
  • Bristol-Myers Squibb (U.S.)
  • Novartis AG (Switzerland)
  • Genetech Inc. (U.S.)
  • AstraZeneca plc (U.K.)
  • Polynoma LLC (CK Life Sciences) (Hong Kong)
  • Sanofi S.A. (France)
  • Amgen Inc. (U.S.)
  • Takeda Pharmaceutical Company (Japan)
  • Merck & Co. Inc. (U.S.)

Related Industry Reports

Compounding Chemotherapy Market

Surface Guided Radiation Therapy Sgrt Devices Market